Creative Planning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,200
Closed -$1.81K 4014
2025
Q3
$1.81K Hold
4,200
﹤0.01% 3879
2025
Q2
$14.1K Buy
+4,200
New +$646K ﹤0.01% 3605
2022
Q2
Sell
-7,500
Closed -$16K 2415
2022
Q1
$16K Buy
+7,500
New +$1.28M ﹤0.01% 2160
2021
Q4
Sell
-4,600
Closed -$15K 2155
2021
Q3
$15K Buy
+4,600
New +$785K ﹤0.01% 2059
2021
Q2
Sell
-27,300
Closed -$5K 2336
2021
Q1
$5K Hold
27,300
﹤0.01% 2518
2020
Q4
$1K Hold
27,300
﹤0.01% 2324
2020
Q3
$6K Hold
27,300
﹤0.01% 2039
2020
Q2
$79K Buy
27,300
+13,600
+99% +$1.98M ﹤0.01% 1701
2020
Q1
$133K Buy
+13,700
New +$1.94M ﹤0.01% 1480
2019
Q4
Sell
-27,300
Closed -$83K 2059
2019
Q3
$83K Hold
27,300
﹤0.01% 1743
2019
Q2
$75K Buy
+27,300
New +$3.78M ﹤0.01% 1772

Other funds holding JNJ

Creative Planning's JNJ Position: Q1 2026 in Review

Creative Planning increased its Johnson & Johnson (JNJ) stake by 7.6% in Q1 2026, buying an estimated $22M and bringing the position to 1,341,281 shares worth $328M. The position accounts for 0.22% of the portfolio, ranked #50.

Creative Planning first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Creative Planning held 1,341,281 shares of Johnson & Johnson worth $328M as of Q1 2026.
  • Creative Planning bought 94,624 Johnson & Johnson shares in Q1 2026, an estimated $22M.
  • Johnson & Johnson made up 0.22% of Creative Planning's portfolio in Q1 2026, its #50 holding.
  • Creative Planning first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.